Abstract: Objective Alzheimer's disease (AD) is one of the major disorders worldwide. Recent research suggests that the amyloid-β precursor protein intracellular domain (AICD) is a potential contributor to AD development and progression. The small AICD is rapidly degraded after processing from the full-length protein. The present study aimed to apply a highly efficient biotinylation approach in vitro to study AICD-associated complexes in neurocytes. Methods By coexpressing Escherichia coli biotin ligase with biotinyl-tagged AICD in the SH-SY5Y neuronal cell line, the effects of AICD overexpression on cell proliferation and apoptosis were analyzed. Besides, AICD-associated nuclear transcriptional complexes were purified and then examined by mass spectrometry. Results Our data showed that AICD overexpression not only affected cell proliferation but also led to apoptosis in differentiated SH-SY5Y cells. Moreover, biotinylation allowed single-step purification of biotinylated AICD-associated complexes from total nuclear extract via high-affinity biotin-streptavidin binding. Following this by mass spectrometry, we identified physically associated proteins, some reported previously and other novel binding partners, CUX1 and SPT5. Conclusion Based on these results, a map of the AICD-associated nuclear interactome was depicted. Specifically, AICD can activate CUX1 transcriptional activity, which may be associated with AICD-dependent neuronal cell death. This work helps to understand the AICD-associated biological events in AD progression and provides novel insights into the development of AD.
Introduction
Alzheimer's disease (AD) is a slowly-progressing and adult-onset neurodegenerative disorder, affecting millions of people worldwide [1] . Affected individuals suffer from progressive loss of cognition and memory as well as language [1] . Studies are still under way to find effective therapeutics or drugs to prevent progression of the disease, in order to improve the quality of life of AD patients.
The pathological hallmarks of AD are significant accumulation of intracellular neurofibrillary tangles and deposition of extracellular senile plaques [1] . Neurofibrillary tangles contain hyper-phosphorylated tau, while senile plaques contain amyloid-β protein (Aβ). Both are toxic to synapses when in a soluble intermediate form [1] [2] [3] , resulting Much work on AD has focused on understanding how
Aβ contributes to the pathogenesis [4] . Aβ is a 38-43 aminoacid peptide derived from amyloid-β precursor protein (APP) [5] , which is a type I transmembrane glycoprotein that can be processed via non-amyloidogenic and amyloidogenic pathways [6] . The non-amyloidogenic processing of APP involves sequential cleavage by α-and γ-secretases: APP is first cleaved by α-secretase to release a soluble ectodomain (APPsα) and a membrane-bound α-C-terminal fragment (α-CTF); the α-CTF is subsequently targeted by γ-secretase, which cleaves it within the transmembrane domain to simultaneously produce p3 (N-terminally truncated Aβ)
and APP intracellular domain (AICD) fragments [5] . Since this pathway precludes Aβ production, it is termed nonamyloidogenic. On the other hand, amyloidogenic processing of APP involves β-and γ-secretases: the β-secretase first cleaves APP to generate a soluble ectodomain (APPsβ) and β-CTF; β-CTF is then cleaved by γ-secretase to produce Aβ and AICD [6] . A transcriptionally active complex of AICD is associated with Fe65 and histone acetyltransferase Tip60 [5] . The γ-secretase can cleave the CTF of APP at different sites, generating different isoforms of Aβ and AICD [7] . For example, cleavage at the valine residue at position 636 (V636) releases Aβ 40 and AICD 59 , the commonly secreted products. Alternatively, cleavage at the ε-cleavage site generates the AICD 50 isoform [7] .
Notably, both amyloidogenic and non-amyloidogenic processing of APP produce a 6-kDa AICD fragment. Unlike
Aβ that is released from cells, AICD is retained in the cytoplasm. Therefore, AICD is proposed to have a more direct or an earlier impact on AD pathology than the extracellular Aβ [7] . Failure of effective Aβ-targeted therapies against AD also supports the proposition that Aβ is not the only factor that causes the disease [8] .
Numerous in vivo studies using transgenic mice have demonstrated a possible role of AICD in AD pathogenesis.
Recent work by Ghosal et al. [2] indicated that AICD is an Aβ-independent factor that contributes to AD. They found that transgenic mice expressing AICD 59 exhibit high levels of active glycogen synthase kinase-3β (GSK3β), which leads to hyper-phosphorylation of tau. As hyper-phosphorylated tau protein begins to aggregate, deficiency in memory becomes apparent. These phenomena in AICD 59 -transgenic mice are often typical in human AD brain. Another study [9] assessed synaptic transmission and learning deficits in transgenic mice that over-express an AICD isoform of 31 amino-acids (AICD 31 ). The AICD 31 is released upon caspase cleavage of APP at the lysine residue at position 664 (D664). The presence of AICD 31 in the cytoplasm induces DNA fragmentation and caspase-3 activation in neurons [7] , which might explain the observed dysfunctions of synaptic transmission and learning in these AICD 31 transgenic mice. A single amino-acid mutation at D664
precludes γ-secretase cleavage and AICD 31 production.
These mutant transgenic mice lacking AICD 31 are protected from the loss of synaptic plasticity and transmission as well as learning. Both studies demonstrated the potential importance of AICD in AD progression and development.
The ability of AICD to activate genes and induce cellular processes is proposed to be attributed to its transactivation function. AICD released intracellularly can form functional complexes with different proteins, translocate into the nucleus, initiate signal transduction and activate the transcription of target genes [3, 10] . Over twenty proteins have been reported to interact with AICD [7] . For example, AICD associates with APP adaptor protein, Fe65 and the Fe65-binding nuclear histone acetylase, Tip60, to form the functional AICD-Fe65-Tip60 complex [6] , which induces the transcription of target genes such as APP and GSK3β [11] . On the other hand, AICD-Mint3-TAZ and AICD-Mint3-YAP are recently uncovered novel mediators of APP signaling [12] . These discoveries provide the insight that AICD may contribute to AD pathogenesis by forming protein complexes to induce the transactivation of gene expression, which eventually leads to disease progression.
The AICD-Fe65-Tip60 transcriptional complex was identified using an artificial system [6] . However, such a system might not reveal the actual biological events occurring in the nuclei of neurons. Hence, the existence of the identified Biotinylation is an efficient approach to isolate and purify biotinyl-tagged protein from crude nuclear extract in vivo and in vitro [13] . Using a similar biotinylation approach, we aimed to isolate AICD-associated complex(es) in a single step by subjecting total nuclear extracts to streptavidin bead binding, to further understand the role of AICDrelated pathways in AD progression. Both cell lines were incubated at 37°C with 5% CO 2 , and the culture media were changed every two days. For seeding cells, the old culture medium was aspirated, and trypsin was added to detach cells from the dish surface.
Subsequently, appropriate fresh culture medium was added to neutralize the trypsin. Re-seeded cells were allowed to grow up to 50%-70% confluence for transfection and infection.
Constructs
The Escherichia coli biotin-protein ligase gene (BirA) and a V5 sequence were cloned into the [14] . 2.6 Nuclear extract preparation Nuclear extracts were prepared according to procedures described previously [13] .
Pseudovirus production and infection
Both groups of cells were harvested by centrifugation at mmol/L. Insoluble material was then removed by ultracentrifugation at 300 000 g for 1 h at 4°C. Nuclear extracts were aliquoted and stored at -70°C.
Streptavidin binding assay
The streptavidin binding assay was performed according to a previous report [13] .
Streptavidin magnetic beads (New England Biolabs, Hertfordshire, UK) were blocked by three washes in TBS with 200 ng/µL bovine serum albumin (Sigma-Aldrich).
Beads were used at 40 µL/2 mg total nuclear extract. Binding was performed in 1× TBS, 350 mmol/L NaCl, and 0.3% Finally, the gel was rinsed thrice with ddH 2 O prior to densitometry (Bio-Rad). Bioimaging Consortium.
Mass spectrometry (MS)

Co-immunoprecipitation 293TN cells were co-trans-
fected with plasmids expressing FLAG-tagged AICD 50 and myc-tagged CUX1 or SPT5. Two days after transfection, total lysates were prepared and incubated with anti-FLAG antibody for 4 h. Then protein-A agarose beads were added. After 2 h, unbound material was washed away with lysis buffer.
Bound material was boiled in Laemmli buffer and subjected to Western blot with anti-myc antibody (Santa Cruz).
Luciferase assay The SH-SY5Y cells were cultured in MEM/F12K supplemented with 10% FBS and antibiotics
(penicillin/streptomycin) in a 37°C incubator with 5% CO 2 . One day after plating, co-transfection of SH-SY5Y cells with relevant DNA constructs was performed by electroporation using Gene Pulser (Bio-Rad). Forty-eight hours later, the cells were washed with PBS and lysed in 200 µL of 1× passive lysis buffer included in the dual luciferase reporter assay system (Promega). Luciferase activity was measured in cell extracts on a luminometer (Molecular Devices, Sunnyvale, CA). The firefly luciferase activity was normalized to Renilla luciferase activity.
Statistical analysis
Comparisons were made using the two-tailed Student's t-test with equal variance. P <0.05
was indicated as statistically significant. (Fig. 1A) .
Results
Biotinylation of AICD
The packaged pseudo-lentiviral particles containing the BirA, AICD 50 or AICD 59 expression constructs, released from 293TN producer cells, were used to infect SH-SY5Y cells. Western blot results showed that biotinylation of BIO-tagged AICD 59 and AICD 50 in the SH-SY5Y cells was only detectable in those co-infected with lentiviral particles containing BirA expression constructs (Fig. 1B) .
However, the band for biotinylated AICD 59 was very faint compared to AICD 50 , probably because AICD 59 can be further cleaved by γ-secretase to release the AICD 50 frag- we focused on analysis of AICD 50 instead of AICD 59 . was located in both the nucleus and cytoplasm, predominantly in the nucleus (Fig. 1C ). 2A) . Also, we used another cell line, neuron-2a (N2a), to investigate the effect of AICD on cell proliferation and similar results were obtained (Fig. S1A) . These results indicated that AICD can cause deficits in cell proliferation in SH-SY5Y cells. Next, we assessed the expression of genes related to the cell cycle and found that the expression of cyclins A, B, and E and the corresponding CDKs 1 and 2
Localization of AICD
AICD
were down-regulated in the AICD-expressing cells (Fig.   2B ), suggesting that AICD directly or indirectly regulates the cell cycle at the transcriptional level. (Fig. 3A) . The same results were found in N2a cells (Fig. S1B) . The apoptosis markers, caspase-3 and caspase-7, were checked after RA treatment. Both were upregulated in the AICD 50/59 -expressing cells compared with the control cells (Fig. 3B, C) . Further, caspase-3/7 enzyme activity was assessed under the same conditions. Enzyme activity was dramatically increased in AICD-stable cells (Fig. 3D ). All these results suggest that AICD induces apoptosis in differentiated SH-SY5Y cells by activating caspase-3/7 activity. to the streptavidin beads was tested by Western blot using streptavidin-HRP conjugate.
AICD overexpression induces apoptosis in differentiated SH-SY5Y cells Although overexpression of AICD
Characterization of AICD-associated transcriptional complexes
A strong band corresponding to the biotinylated AICD 50 in the eluted fraction was found (Fig. 4A) . Conversely, biotinylation was absent from the unbound fraction. Background binding was also negligible due to the absence of a biotinylated band in the BirA control.
Since the BIO-tagged AICD 50 was efficiently recovered from the eluted fraction after streptavidin bead binding, the protein complexes associated with BIO-tagged AICD 50
should also be found only in the eluted fraction. By comparing the bands recovered from the eluted fractions of BirA control and BirA/AICD 50 , several distinct bands were found for biotinylated AICD 50 (BirA/AICD 50 ) (Fig.   S2 ). These bands might correspond to the purified BIOtagged AICD 50 -associated protein complexes, so they were excised for tandem MS-MS analysis. Results showed that the proteins were associated with AICD 50 (Fig. 4B, C) , and may cooperate in AICD-related transcriptional activity.
Fe65, an important AICD binding partner [6] , was confirmed in this work, as well as its two homologs, Fe65L1 and Fe65L2. Some other previously suggested binding partners were also detected: SET [15] , MED12 [16] , and Numb [17] . Importantly, we found two transcription factors, CUX1 and SPT5, as novel AICD binding partners. Their interactions with AICD 50 were confirmed by co-immunoprecipitation assay (Fig. 4D) . Moreover, AICD enhanced the activity of CUX1-dependent activation of the MKLP1 promoter (Fig.   4E ). These results suggested that AICD modulates cell proliferation and apoptosis through different pathways, besides the canonical Fe65-dependent pathway.
Discussion
The present study aimed to reveal AICD-associated binding partners in SH-SY5Y cells by using the biotinylation approach. The small-molecule AICDs are unstable in cells and are often rapidly degraded upon release [3] , making their study difficult. To overcome this, we used Biotin has an extremely strong affinity for streptavidin, with a dissociation constant between 10 -13 and 10 -15 mol/L [13] . Hence, biotin-streptavidin binding allows highly efficient purification of biotinylated proteins as well as their associated complexes from crude extracts. Indeed, our data revealed efficient binding of biotinylated AICD 50 to streptavidin beads in relation to the negligible background binding in BirA controls of both eluted and unbound materials from the beads. In addition, the protein complexes associated with AICD 50 were purified from nuclear extracts in just a single step. Our study revealed both nuclear and cytoplasmic localizations of AICD in SH-SY5Y cells, supporting the idea that intracellularly-released AICD can translocate into the nucleus. Many studies revealed that translocation of AICD into the nucleus is dependent on the Fe65 adaptor protein [3, 6, 18] , while others showed that nuclear translocation of AICD may be indirectly through Fe65 [2] .
Our work confirmed that AICD is associated with Fe65 in the nucleus, indicating an Fe65-dependent translocation.
The slow growth observed in AICD 59 and AICD 50 stable SH-SY5Y cells was due to reduced rates of cell proliferation. This phenomenon has been neglected in previous work, much of which emphasized the apoptotic activity of AICD. The reduced cell proliferation may be due to the fact that AICD activates p53, which then regulates the cell cycle check point. Another possibility is that other AICD binding partners also function in this process. The two novel binding partners found in this study, CUX1 and SPT5, may participate, because they have been found to play broad roles in mammalian development by regulating gene expression and function in controlling cell proliferation [19, 20] .
It would be of interest to investigate the extent of apoptosis mediated by the intracellular domains, since this may be an important contributor to AD pathology. Cell death signals such as GSK3β, p53 and caspase activation transmitted by an AICD-dependent transcriptionally active complex have been reported [2, 7] . For instance, AICD 31
induces DNA fragmentation and caspase-3 activation [7] .
Besides, another study has reported a reduction of β-catenin level in AICD 59 -expressing rat primary neurons [11] . A low β-catenin level can cause the loss of cell-cell contact and make neurocytes more vulnerable to apoptosis [7, 21] . Here, we confirmed that AICD activates caspase-3/7 activity and found that AICD could activate CUX1-dependent activity, a potential add-on for AICD-dependent neuronal cell death.
We hypothesize that AICD may be associated with different 
